Evidence map›Paper›PMID 34682650›Full record

ArticleInternational journal of environmental research and public health2021

Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic.

Tania Buttiron Webber, Silvia Giuliano, Carlotta Patrone, Irene Maria Briata, Maria Franconeri, Francesca Marceca, Monica Magnani, Fortuna Paciolla, Nicoletta Provinciali, Carlotta Defferrari and 7 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Tania Buttiron WebberMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.ORCID 0000-0002-3605-2828
Silvia GiulianoMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Carlotta PatroneOffice Innovation, Development and Lean Application, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Irene Maria BriataMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Maria FranconeriMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Francesca MarcecaMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Monica MagnaniMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.ORCID 0000-0003-1269-5375
Fortuna PaciollaMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Nicoletta ProvincialiMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.ORCID 0000-0002-7803-3852
Carlotta DefferrariMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Matteo ClavarezzaMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Mauro D'AmicoMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Alberto GozzaMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Monica BoitanoMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Mattia Alessio-MazzolaDepartment of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Viale Benedetto XV, 6, 16132 Genoa, Italy.ORCID 0000-0001-6741-3713
Isabella CevascoHealthcare Professions Structure, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Andrea DeCensiMedical Oncology, Galliera Hospital, Mura delle Cappuccine 14, 16128 Genoa, Italy.
Ente Ospedaliero Ospedali Galliera · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer patients are exposed to a greater risk of COVID-19 infection, resulting in treatment delays and unnecessary hospitalizations. International authorities have suggested reducing visits to hospitals and guarantee continuity of care. We developed a home care project called Home Se-Cure (HSC) to guarantee the continuity of oral, intramuscular, and subcutaneous cancer therapy during COVID-19. The Home Se-Cure project included cancer patients living near Galliera Hospital. Patients received home visits by registered nurses (RNs), whoperformed blood tests and delivered cancer therapies. Patients were instructed to take drugs after blood test results and therapy confirmation by oncologists. Sixty-six patients decided to participate and 38 declined the service. A customer satisfaction questionnaire was administered to a subgroup of patients participating in the project. The most prevalent disease in the HSC group was prostate cancer. The mean age of the patients in HSC was 78.4 years and 68.9 in the decliner group. The majority of the HSC participants appreciated the project because they could stay at home (71%) and reduce the risk of COVID-19 contagion (67.7%). Compared to decliners, the time the study group saved was 2033 hours. HSC guaranteed the continuity of care during the COVID-19 pandemic by reducing the number of patients in the hospital and avoiding crowds in the waiting room.

Indexed as

COVID-19Home Care ServicesNeoplasmsAgedHumansMalePandemicsSARS-CoV-2cancer patientsCOVID-19 pandemichome care servicenursingSARS-CoV-2

Identifiers

PMID34682650
PMCPMC8535406
OpenAlexW3207736116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.